[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [HEALTH]

2 clusters · 6 sources · 4 days · First seen · Last updated

Medical research on cardiovascular and stroke risk factors

Overview

Medical research has identified several physiological and visible indicators for cardiovascular and neurological health risks. Studies from Stanford University have linked xanthelasma—yellowish deposits on the eyelids—to increased risks of heart attack, stroke, and transient ischemic attacks (TIA), suggesting these deposits may serve as visible markers for atherosclerosis and lipid metabolism issues.

Additional research has focused on blood pressure and heart rhythm management. Data from the SPRINT clinical trial indicated that intensive blood pressure control, targeting a systolic limit of 120 mmHg, significantly slowed the progression of cerebral small vessel disease. Furthermore, the SINGLE AF trial addressed the complexities of treating patients with atrial fibrillation, emphasizing the need for personalized clinical decisions to balance stroke prevention against bleeding risks in intermediate-risk patients.

Entities

Stanford University · Massachusetts General Hospital · UT Health San Antonio · Atherosclerosis

Timeline

  1. [HEALTH] 2 sources
    Medical studies link xanthelasma and atrial fibrillation to cardiovascular risks

    New medical studies examine cardiovascular risk factors, including the management of intermediate-risk atrial fibrillation and the link between xanthelasma skin deposits and increased stroke or heart attack.

  2. [HEALTH] 4 sources
    Medical studies link eyelid deposits and blood pressure to heart and brain health

    Medical studies link eyelid yellow deposits (xanthelasma) to heart disease risks and show that stricter blood pressure control can significantly slow the progression of brain vessel disease.

Sources

blikkruzs.blikk.hu · egeszsegkalauz.hu · liner.hu · tech.everyeye.it · torrinomedica.it · toysforlife.co.nz